Conference abstractPublished 3 May 2023
Can acquired drug resistance be reversed/prevented?
Singh Biotechnology, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Targeted therapies have improved the pharmacological treatment of cancer patients. Unfortunately, in many cases, after an initial response, their efficacy is lost. This undesirable situation is called Acquired Drug Resistance (ADR). The involvement of the signal transducer and activator of transcription 3 (STAT3) in the development of ADR has been demonstrated in studies conducted in animal models and in cancer patients. Stat3 is present in all cells and under normal conditions is transiently activated. However, in pathological conditions, such as cancer, STAT3 becomes constitutively phosphorylated resulting in the aberrant persistent form called p-STAT3. STAT3, considered the master regulator of intracellular signals, is located downstream of all signaling pathways involved in cancer. As result of the significant crosstalk among them, the pharmacological inhibition of any of these pathways activates STAT3 resulting in p-STAT3 which is responsible for all the changes that cause the development of ADR. ADR has been observed during treatment with all types of anticancer therapies, chemotherapies and targeted therapies including checkpoint inhibitors and the two recently approved KRAS inhibitors. The anticancer efficacy of STAT3 inhibitors, used alone or in combination has been shown in animal models and in patients that harbor p-STAT3. Several Stat3 inhibitors are currently in clinical development. As soon as they reach the market, any rational pharmacological treatment should include a STAT3 inhibitor. This combination will reverse/prevent ADR and induce long-term, effective responses.
Subjects
BiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Cell Science & Therapy
- SubjectBiology
- BylineArticles whose byline prints “Hector J Gomez”
